Literature DB >> 28315545

Oral Anticancer Agents: An Intervention to Promote Medication Adherence and Symptom Management
.

Sandra L Spoelstra1, Alla Sikorskii2, Atreyee Majumder3, Peggy S Burhenn4, Monica Schueller5, Barbara Given3.   

Abstract

Symptom burden and poor adherence to oral anticancer agents remain significant clinical problems. This study examined feasibility, preliminary efficacy, and satisfaction with ADHERE, a nurse practitioner intervention that promotes symptom management and adherence among patients prescribed oral agents. The intervention group (which received one semistructured, face-to-face session followed by three weekly telephone sessions using motivational interviewing, brief cognitive-behavioral therapy, and a toolkit to promote self-management) had significantly lower symptom severity postintervention. Self-reported adherence was high and did not differ by group. Patients reported being highly satisfied with the ADHERE intervention.
.

Entities:  

Keywords:  advanced practice registered nurse; oral anticancer agent; patient education


Mesh:

Substances:

Year:  2017        PMID: 28315545     DOI: 10.1188/17.CJON.157-160

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  7 in total

1.  Symptom-based interventions to promote quality survivorship.

Authors:  Christina Amidei
Journal:  Neuro Oncol       Date:  2018-11-09       Impact factor: 12.300

2.  Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review.

Authors:  Shoshana M Rosenberg; Keith J Petrie; Annette L Stanton; Lan Ngo; Emma Finnerty; Ann H Partridge
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

3.  ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.

Authors:  Sarah M Belcher; Emily Mackler; Benyam Muluneh; Pamela K Ginex; Mary K Anderson; Elizabeth Bettencourt; Ryan K DasGupta; Jennifer Elliott; Erica Hall; Michelle Karlin; Diana Kostoff; Victoria K Marshall; Vanessa E Millisor; Maegan Molnar; Susan M Schneider; Janelle Tipton; Susan Yackzan; Kristine B LeFebvre; Kapeena Sivakumaran; Haya Waseem; Rebecca L Morgan
Journal:  Oncol Nurs Forum       Date:  2022-06-17       Impact factor: 1.803

4.  Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting.

Authors:  Natasha Khrystolubova; Monica Shieh; Anjan J Patel; Ray Bailey
Journal:  J Oncol Pharm Pract       Date:  2019-03-04       Impact factor: 1.809

5.  Understanding Barriers to Oral Therapy Adherence in Adults With Acute Myeloid Leukemia.

Authors:  Ashley Leak Bryant; Ya-Ning Chan; Jaime Richardson; Matthew Foster; Susie Owenby; Debra Wujcik
Journal:  J Adv Pract Oncol       Date:  2020-05-01

6.  Factors associated with adherence to follow-up calls in cancer patients receiving care at a community oncology practice.

Authors:  Shanada Monestime; Ray Page; Nicole Shaw; Randy Martin; William Jordan; Jessica Rangel; Subhash Aryal
Journal:  J Oncol Pharm Pract       Date:  2020-08-20       Impact factor: 1.809

7.  Patient-doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center.

Authors:  Jochen Hefner; Sara Berberich; Elena Lanvers; Maria Sanning; Ann-Kathrin Steimer; Volker Kunzmann
Journal:  Patient Prefer Adherence       Date:  2018-09-21       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.